Results 81 to 90 of about 2,554,843 (232)

Influence of TEM-1 β-Lactamase on the Pharmacodynamic Activity of Simulated Total versus Free-Drug Serum Concentrations of Cefditoren (400 Milligrams) versus Amoxicillin-Clavulanic Acid (2,000/125 Milligrams) against Haemophilus influenzae Strains Exhibiting an N526K Mutation in the ftsI Gene

, 2007
The aim of this study was to explore bactericidal activity of total and free serum simulated concentrations after the oral administration of cefditoren (400 mg, twice daily [bid]) versus the oral administration of amoxicillin-clavulanic acid extended ...
Coronel, Pilar, Alou Cervera, Luis, Echeverría, Olatz, Torrico, Martha, Prieto Prieto, José, Aguilar, Lorenzo, González Hidalgo, Natalia, Cafini, Fabio, Sevillano Fernández, David, Giménez, María José   +9 more
core   +1 more source

Biomaterials for Reconstructive Treatment of Peri‐Implantitis

Journal of Periodontal Research, EarlyView.
Reconstructive therapy should be implemented in contained defects. Various bone filler materials with or without a barrier membrane and/or adjunctive biologics may be applied. ABSTRACT Peri‐implantitis is a pathological condition affecting the tissues surrounding dental implants, marked by inflammation of the peri‐implant connective tissue and ...
Ausra Ramanauskaite, Anton Sculean, Emilio A. Cafferata, Frank Schwarz   +3 more
wiley   +1 more source

Novel Antibiotic Combinations of Diverse Subclasses for Effective Suppression of Extensively Drug-Resistant Methicillin-Resistant Staphylococcus aureus (MRSA)

International Journal of Microbiology, 2020
The emergence of multidrug-resistant pathogens such as methicillin-resistant Staphylococcus aureus (MRSA), the chief etiological agent for a range of refractory infections, has rendered all β-lactams ineffective against it.
Shumyila Nasir, Muhammad Sufyan Vohra, Danish Gul, Umm E Swaiba, Maira Aleem, Khalid Mehmood, Saadia Andleeb   +6 more
doaj   +1 more source

Platelet‐Rich Fibrins as Local Drug‐Delivery Carriers

Journal of Periodontal Research, EarlyView.
Autologous platelet concentrates (APCs), particularly platelet‐rich fibrin (PRF), act as biologically active fibrin scaffolds, capable of entrapping and gradually releasing therapeutic agents in oral and periodontal therapy. The incorporation of bioactive compounds, such as antibiotics, antifungals, vitamins, antidiabetic drugs, and exosomes, enhances ...
Karim M. Fawzy El‐Sayed, Christof E. Dörfer   +1 more
wiley   +1 more source

Antibacterial therapy for acute streptococcal tonsillopharyngitis: results of a randomized comparative clinical trial with amoxicillin + clavulanic acid EXPRESS

Терапевтический архив
Background. Acute tonsillopharyngitis is one of the most common types of respiratory tract infections. In case of bacterial etiologies of the disease, penicillin antibiotics are prescribed, in particular amoxicillin + clavulanic acid.
Sergey A. Karpishchenko, Marina А. Ryabova, Olga M. Kolesnikova, Mikhail Yu. Ulupov   +3 more
doaj   +1 more source

Antimicrobial Susceptibility Patterns of Haemophilus influenzae and Streptococcus pneumoniae in Respiratory Tract Infections: A Retrospective Observational Real-world Database Study in India [PDF]

Journal of Clinical and Diagnostic Research
Introduction: Antimicrobial Resistance (AMR) presents a major worldwide challenge to public health, leading to significant levels of illness and death in India.
V Balaji, Vishal Singh, Puja Nijhara, Krunal Dalal, Sanket Sawant, Sebin Thomas, Lindsey Teichman, Shilpa Patkar   +7 more
doaj   +1 more source

The effects of far‐UVC irradiation on the presence and concentration of ESKAPEE pathogens on hospital surfaces: Study protocol for a multi‐site, double‐blinded randomized controlled trial in La Paz, Bolivia

Photochemistry and Photobiology, EarlyView.
The protocol of a multi‐site, double‐blinded, clustered randomized controlled trial (cRCT) with a binary outcome of the presence of viable presumptive ESKAPEE pathogens on surfaces in and around hospital sinks is to be implemented in two Bolivian hospitals.
Lindsay B. Saber, Melani Rojas, Darcy M. Anderson, Deverick J. Anderson, Holger Claus, Ryan Cronk, Karl G. Linden, Megan E. J. Lott, Lewis J. Radonovich Jr., Bobby G. Warren, Richard D. Williamson, Richard L. Vincent, Sergio Gutiérrez‐Cortez, Carla Calderón Toledo, Joe Brown   +14 more
wiley   +1 more source

Impact of oral amoxicillin and amoxicillin/clavulanic acid treatment on bacterial diversity and ß-lactam resistance in the canine faecal microbiota [PDF]

, 2019
BACKGROUND: Aminopenicillins with or without a β-lactamase inhibitor are widely used in both human and veterinary medicine. However, little is known about their differential impact on the gut microbiota and development of antimicrobial resistance ...
Espinosa-Gongora, Carmen, Kieler, I N, Saint-Lu, N, Sablier-Gallis, F, de Gunzburg, Jean, Corbel, T, Sablier-Gallis, Frédérique, Pires dos Santos, T, Saint-Lu, Nathalie, Kieler, Ida Nordang, Gudeta, D D, Hugon, P, Bjørnvad, Charlotte Reinhard, Jessen, L R, de Gunzburg, J, Nevière, Agathe, Pires Dos Santos, Teresa, Damborg, Peter, Sayah-Jeanne, S, Nevière, A, Jessen, Lisbeth Rem, Sayah-Jeanne, Sakina, Bjørnvad, C R, Guardabassi, Luca, Guardabassi, L, Damborg, P, Corbel, Tanguy, Hugon, Perrine, Espinosa-Gongora, C, Gudeta, Dereje Dadi   +29 more
core   +1 more source

Exploring the activity of a novel orally bioavailable β-lactam-β-lactamase inhibitor combination, ceftibuten-ledaborbactam, against Enterobacterales-carrying blaOXA-48

Microbiology Spectrum
Ledaborbactam is a novel boronic-acid inhibitor of class A, C, and D β-lactamases, including OXA-48, being developed in combination with ceftibuten. Herein, we examined the in vitro activity of this combination vs.
Maria F. Mojica, Elise T. Zeiser, Scott A. Becka, David A. Six, Greg Moeck, Robert A. Bonomo, Krisztina M. Papp-Wallace   +6 more
doaj   +1 more source

Safety and Tolerability of Nebulized Amoxicillin-Clavulanic Acid in Patients with COPD (STONAC 1 and STONAC 2) [PDF]

, 2016
The safety and tolerability of nebulized amoxicillin clavulanic acid were determined in patients with stable COPD and during severe exacerbations of COPD.
Assink, M.D.M., Brusse-Keizer, M.G.J., van der Palen, J.A.M.; id_orcid, Nijdam, L.C., van der Palen, Jacobus Adrianus Maria, de Saegher, M.E.A., Movig, K.L.L., Kuijvenhoven, J.C., van der Valk, P.D.L.P.M.   +8 more
core   +1 more source